Vaccitech plc
NASDAQ: VACC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- William J. Enright MBA
- Employees
- 33
- Headquarters
- Oxford, United Kingdom
- IPO year
- 2021
- Market cap
- $192.7M
- Website
- https://www.vaccitech.co.uk
Loading VACC…
Loading profile data…Frequently asked questions about VACC
What does Vaccitech plc (VACC) do?
Vaccitech plc is a clinical-stage biopharmaceutical company focused on developing cutting-edge T-cell immunotherapeutics and vaccines. Their mission is to treat and prevent a variety of infectious diseases and cancers. The company's therapeutic pipeline includes several programs undergoing clinical evaluation: VTP-300 is in Phase 1/2a clinical t...
Where does VACC trade?
Vaccitech plc (VACC) trades on the NASDAQ Global Market.
What sector is VACC in?
Vaccitech plc (VACC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Vaccitech plc?
William J. Enright MBA is the chief executive officer of Vaccitech plc (VACC).
Where is Vaccitech plc headquartered?
Vaccitech plc is headquartered in United Kingdom.
Does VACC pay a dividend?
Vaccitech plc (VACC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VACC go public?
Vaccitech plc (VACC) completed its initial public offering in 2021.